Real-World Evidence Solutions Market to Reach $10.83 Billion by 2030, Driven by Shift to Value-Based Care and Accelerated Drug Development
According to MarketsandMarkets™, The global real-world evidence (RWE) solutions market is projected to grow from USD 5.42 billion in 2025 to USD 10.83 billion by 2030, at a CAGR of 14.8% during the forecast period. Market expansion is being driven by the growing shift toward value-based care, increasing prevalence of chronic diseases, and rising innovation across pharmaceuticals and medical devices.
Browse 441 market data tables and 59 figures spread across 376 pages and an in-depth TOC of the global Real World Evidence Solution Market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76173991
Healthcare stakeholders are increasingly leveraging RWE solutions to generate actionable insights from real-world data, enabling faster and more cost-efficient drug development, improved clinical outcomes, and enhanced decision-making across the healthcare ecosystem. The increasing availability of large-scale healthcare data—combined with the need to deliver high-quality, evidence-based care—is further accelerating adoption.
Services Segment Leads Market Growth
By component, the services segment accounted for the largest share of the market in 2024. This segment includes advanced analytics and consulting services, which play a critical role in extracting meaningful insights from complex healthcare datasets.
Advanced analytical capabilities enable stakeholders to efficiently process and interpret real-world patient data, supporting clinical, operational, and regulatory decision-making. The growing demand for data-driven insights across the healthcare value chain continues to strengthen the position of services within the RWE ecosystem.
Drug Development & Approvals Segment Dominates Applications
By application, the drug development and approvals segment held the largest share of the market in 2024. Within this segment, oncology emerged as the leading therapeutic area, driven by the increasing global burden of cancer and intensified focus on developing targeted therapies.
RWE is playing a pivotal role in accelerating drug approvals, optimizing clinical trial design, and supporting regulatory submissions. By providing insights into real-world treatment effectiveness and safety, RWE helps reduce development timelines and mitigate risks associated with costly drug recalls.
Pharmaceutical & Biotechnology Companies Lead End-User Adoption
Pharmaceutical and biotechnology companies accounted for the largest share of the market in 2024. These organizations rely heavily on real-world data to support drug development, clinical trials, and regulatory approval processes.
The increasing use of RWE studies enhances understanding of treatment outcomes in real-world settings, complementing traditional clinical trial data. This enables more informed decision-making and supports the development of safer, more effective therapies.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76173991
North America Maintains Market Leadership
North America held the largest share of the global RWE solutions market in 2024. The region’s leadership is attributed to a favorable regulatory environment, widespread adoption of electronic health records (EHRs), and increasing use of RWE by healthcare payers and providers.
The presence of leading market players, coupled with strong digital health infrastructure and growing demand for data-driven healthcare insights, continues to support regional growth.
Competitive Landscape
Key players operating in the real-world evidence solutions market include IQVIA Inc. (US), Merative (US), Optum Inc. (US), ICON Plc (Ireland), Syneos Health (US), Parexel International Corporation (US), Tata Consultancy Services (India), Oracle (US), Elevance Health (US), SAS Institute Inc. (US), Aetion Inc. (US), TriNetX, LLC (US), Trinity (US), Cognizant Technology Solutions Corporation (US), Cegedim Health Data (France), Verantos (US), Medpace Holdings Inc. (US), Flatiron Health (US), Fortrea (US), and Medidata (US), among others.
These companies are focused on expanding analytics capabilities, strengthening data partnerships, and advancing AI-driven platforms to unlock the full potential of real-world data.
Related Reports:
Healthcare Analytics Market – Global Forecast to 2031
Revenue Cycle Management (RCM) Market – Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/real-world-evidence-solution-market-76173991.html
